Search results for "Osteoarthriti"

Presenza di Osteoartrite in un campione scheletrico proveniente da una necropoli paleocristiana di Marsala (Italia)

2008

New molecular targets for the treatment of osteoarthritis.

2009

Osteoarthritis (OA) is a chronic degenerative joint disorder characterized by destruction of the articular cartilage, subchondral bone alterations and synovitis. Current treatments are focused on symptomatic relief but they lack efficacy to control the progression of this disease which is a leading cause of disability. Therefore, the development of effective disease-modifying drugs is urgently needed. Different initiatives are in progress to define the molecular mechanisms involved in the initiation and progression of OA. These studies support the therapeutic potential of pathways relevant in joint metabolism such as Wnt/beta-catenin, discoidin domain receptor 2 or proteinase-activated rece…

EFFICACIA NELLA PRATICA CLINICA DI UN SUPPLEMENTO A BASE DI GLUCOSAMINA SOLFATO(GS), CONDROITINA SOLFATO (CS), COLLAGENE IDROLIZZATO DI TIPO B, ACIDO…

2012

Aim: Osteoarthritis (OA) is a degeneration of articular cartilage. four components of the cartilage structure, glucosamine, chondroitin collagen type II and hyaluronic acid are available in a food supplements. It has been claimed that they reduce the pain of OA and help rebuild cartilage in patients with early OA. Methods: A multicentre, randomized, double-blind ascorbic acid controlled study was carried out in patients with osteoarthritis of the knee. The purpose of the study was to evaluate the effectiveness of a food supplement sachet containing glucosamine sulfate (500 mg), chondroitin sulfate (400 mg), hydrolyzed collagen tipe II and hyaluronic acid mixture (300 mg), L-carnitine fumara…

A multicenter observational study on the role of comorbidities in the recurrent episodes of benign paroxysmal positional vertigo

2014

Objective: Primary objective of this study was to find a statistical link between the most worldwide comorbidities affecting the elderly population (hypertension, diabetes, osteoarthrosis, osteoporosis and depression) and recurrent episodes of BPPV. Secondary objective was defining possible "groups of risk" for people suffering recurrent positional vertigo related to the presence of a well documented comorbidity. Methods: This was an observational, cross-sectional, multicenter, spontaneous, non-pharmacological study. The data of 1092 patients suffering BPPV evaluated in 11 different Departments of Otolaryngology, Otoneurology and Neurology, referring Centers for positional vertigo evaluatio…

COX-2 inhibition and pain management: a review summary

2005

Cyclooxygenase-2 selective inhibitors have long been regarded as potent anti-inflammatory drugs for the treatment of arthritis, osteoarthritis and dysmenorrhea. The reports of cardiovascular risk and the subsequent withdrawal of rofecoxib, and recently valdecoxib, has called the therapeutic potential of coxibs into question. Currently, according to the latest decisions of the US Food and Drug Administration and European Medicines Agency, the approval of valdecoxib has been refused for 1 year due to an increased rate of cardiovascular risks and serious skin reactions. There are restrictions concerning the use of all other coxibs. The short-time use of coxibs, however, in anti-inflammatory tr…

Pathogenesis of Anterior Knee Pain in the Active Young: Is There a Relation Between the Presence of Patellofemoral Malalignment and Pain?

2012

This chapter is not intended to advocate for a particular surgical technique, but it does provide insight into improving our understanding of the pathophysiology of anterior knee pain syndrome. Our objectives were: to identify a relationship, or lack of one, between the presence of PFM and the presence of anterior knee pain; to analyze the long-term response of VMO muscle fibers to increased resting length; and to determine the incidence of patellofemoral osteoarthritis after IPR surgery. Our findings indicate (1) that not all PFM knees show symptoms; that is, PFM is not a sufficient condition for the onset of symptoms, at least in postoperative patients; (2) that the advancement of VMO has…

Genetic disorders of connective tissues

1991

Due to the growing knowledge of structure and function of extracellular matrix proteins, congenital abnormalities of connective tissues are identified or suspected in an increasing number of clinical disorders. In osteogenesis imperfecta and two subtypes of Ehlers-Danlos syndrome, the affected matrix proteins were identified and mutations in the corresponding genes (procollagen type I and type III, respectively) could be demonstrated. Some forms of chondrodysplasia were shown to be associated with mutations in the gene encoding for the cartilage-specific collagen (type II). In part, the clinical phenotype is determined by the tissue-specific distribution of these collagens. However, the cor…

Modification of longitudinal relaxation time (T1) as a biomarker of patellar cartilage degeneration

2010

Abstract Objectives To study the viability of longitudinal relaxation time ( T1 ) of patellar cartilage as a biomarker of the degree of degeneration. Material and methods We included 15 subjects classified into three groups according to clinical criteria (pain, functional limitation, and duration of symptoms) and imaging criteria as follows: (a) normal (3 men, 2 women; age 30 ± 14 years), (b) with initial degeneration of the patellar cartilage (3 men, 2 women; age 30 ± 6 years), or (c) with advanced degeneration (3 men, 2 women; age 57 ± 10 years). All underwent MRI examination using special echo-gradient sequences to segment the cartilage and calculate the T1 maps. We selected the entire c…

Role of peroxiredoxin 6 in the chondroprotective effects of microvesicles from human adipose tissue-derived mesenchymal stem cells

2021

Este artículo se encuentra disponible en la página web de la revista en la siguiente URL: https://www.sciencedirect.com/science/article/pii/S2214031X21000656?via%3Dihub Background: Osteoarthritis (OA) is a joint disease characterized by cartilage degradation, low-grade synovitis and subchondral bone alterations. In the damaged joint, there is a progressive increase of oxidative stress leading to disruption of chondrocyte homeostasis. The modulation of oxidative stress could control the expression of inflammatory and catabolic mediators involved in OA. We have previously demonstrated that extracellular vesicles (EVs) present in the secretome of human mesenchymal stem cells from adipose tissu…

Aceclofenac versus piroxicam in the management of osteoarthritis of the knee: A double-blind controlled study

1994

Abstract The objective of this study was to compare the efficacy and tolerability of aceclofenac tablets 100 mg twice daily with piroxicam tablets 20 mg once daily in the treatment of osteoarthritis of the knee or gonarthritis. A randomized, double-blind, controlled study of 3 months' duration was conducted in patients with gonarthritis diagnosed according to the World Health Organization criteria. A total of 212 patients were recruited; 205 patients fully complied with the inclusion-exclusion criteria. Of these, 103 received aceclofenac and 102 received piroxicam. Fourteen patients in the aceclofenac group and 12 patients in the piroxicam group who failed to complete the 3-month treatment …